On June 8, the American Red Cross will implement changes to donor eligibility criteria announced earlier this spring by the U.S. Food and Drug Administration in its updated guidance for human immunodeficiency virus, malaria and variant Creutzfeldt-Jakob disease or “mad cow.” We welcome these changes, which we hope will allow more individuals to donate much-needed blood, and ensure we can meet patient needs throughout this pandemic and beyond.
We encourage individuals who believe they may now be eligible to give under the new FDA guidelines to visit RedCrossBlood.org to learn more about donor eligibility requirements that help ensure the safety of both blood donors and blood recipients.
It’s important to emphasize that we continue to work diligently to remove current Red Cross deferrals under the former eligibility policies which will be updated over the upcoming weeks and months. These deferrals cannot be removed at our blood drives or donation centers due to onsite system access limitations. People may contact our Red Cross Donor and Client Support Center at 1-866-236-3276 for information about donor eligibility and deferrals.
The Red Cross also remains steadfast in our commitment to ensure that every blood recipient has access to safe, lifesaving blood products when needed.